Chubb stock price target maintained at $325 by JMP on favorable book value outlook

JMP Securities reiterated its Market Outperform rating and $325 price target on Chubb Corporation (NYSE:CB), projecting a 1.8% positive mark-to-market impact on the insurer's book value from recent fixed income and equity market movements, positioning it favorably among peers. This bullish assessment contrasts with Goldman Sachs' recent decision to lower its Chubb price target to $299, citing concerns over a greater-than-expected deceleration in North American Commercial pricing, highlighting a divergence in analyst sentiment regarding the insurer's near-term outlook.

Analysis

Analyst sentiment on Chubb Corporation (CB) is divergent, presenting a nuanced picture for investors. JMP Securities reiterated a 'Market Outperform' rating with a $325 price target, citing a projected 1.8% positive mark-to-market impact on the company's book value from recent fixed income and equity market movements. This positions Chubb as one of the most favorably positioned insurers in JMP's coverage, second only to RLI Corp. (RLI) which is projected for a 1.9% impact but holds a lesser 'Market Perform' rating from the firm. This bullish view is supported by Keefe, Bruyette & Woods, which also reiterated an 'Outperform' rating following Q2 2025 earnings. However, Goldman Sachs expressed caution, lowering its price target on Chubb from $309 to $299 due to concerns over a greater-than-expected deceleration in North American Commercial pricing. Fundamentally, Chubb's position is reinforced by a 'GREAT' financial health score from InvestingPro and a recently declared quarterly dividend of $0.97 per share, signaling stable capital returns.

Key Decisions for Investors

• Investors should weigh the bullish thesis from JMP and KBW, based on favorable mark-to-market impacts on book value, against Goldman Sachs' caution regarding a potential slowdown in North American commercial pricing.
• The deceleration in commercial pricing is a key metric to monitor, as it represents the primary point of contention among analysts and could be a significant driver of future stock performance.
• For income-focused and long-term investors, the consistent $0.97 quarterly dividend and strong underlying financial health score provide a degree of fundamental support amidst the conflicting analyst outlooks.
• Consider the relative value proposition, as JMP's analysis implies Chubb may have a more attractive overall profile than peers like RLI, despite a marginally lower projected book-value tailwind from market movements.